GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (CHIX:YPSNz) » Definitions » Gross Margin %

Ypsomed Holding AG (CHIX:YPSNZ) Gross Margin % : 36.24% (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Ypsomed Holding AG Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Ypsomed Holding AG's Gross Profit for the six months ended in Sep. 2024 was CHF117.4 Mil. Ypsomed Holding AG's Revenue for the six months ended in Sep. 2024 was CHF324.0 Mil. Therefore, Ypsomed Holding AG's Gross Margin % for the quarter that ended in Sep. 2024 was 36.24%.


The historical rank and industry rank for Ypsomed Holding AG's Gross Margin % or its related term are showing as below:

CHIX:YPSNz' s Gross Margin % Range Over the Past 10 Years
Min: 23.07   Med: 29.13   Max: 35.44
Current: 35.44


During the past 13 years, the highest Gross Margin % of Ypsomed Holding AG was 35.44%. The lowest was 23.07%. And the median was 29.13%.

CHIX:YPSNz's Gross Margin % is ranked worse than
72.67% of 805 companies
in the Medical Devices & Instruments industry
Industry Median: 51.89 vs CHIX:YPSNz: 35.44

Ypsomed Holding AG had a gross margin of 36.24% for the quarter that ended in Sep. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Ypsomed Holding AG was 1.90% per year.


Ypsomed Holding AG Gross Margin % Historical Data

The historical data trend for Ypsomed Holding AG's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG Gross Margin % Chart

Ypsomed Holding AG Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.07 23.49 24.49 28.26 34.47

Ypsomed Holding AG Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.80 29.68 34.39 34.54 36.24

Competitive Comparison of Ypsomed Holding AG's Gross Margin %

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Gross Margin % falls into.



Ypsomed Holding AG Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Ypsomed Holding AG's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=189.1 / 548.457
=(Revenue - Cost of Goods Sold) / Revenue
=(548.457 - 359.404) / 548.457
=34.47 %

Ypsomed Holding AG's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=117.4 / 324.005
=(Revenue - Cost of Goods Sold) / Revenue
=(324.005 - 206.579) / 324.005
=36.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Ypsomed Holding AG  (CHIX:YPSNz) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Ypsomed Holding AG had a gross margin of 36.24% for the quarter that ended in Sep. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Ypsomed Holding AG Gross Margin % Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ypsomed Holding AG Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services.

Ypsomed Holding AG Headlines

No Headlines